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Background. Multimodality imaging is recommended to diagnose infective endocarditis.
Value of additional imaging to echocardiography in patients selected by a previously proposed
flowchart has not been evaluated.
Methods. An observational single-center study was performed. Adult patients suspected of
endocarditis/device infection were prospectively and consecutively enrolled from March 2016 to
August 2017. Adherence to a diagnostic imaging-in-endocarditis-flowchart was evaluated in 176
patients. Imaging techniques were compared head-to-head in 46 patients receiving echocar-
diography (transthoracic plus transesophageal), multi-detector computed tomography
angiography (MDCTA), and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET/
CT).
Results. 69% of patients (121/176) adhered to the flowchart. Sensitivity of echocardiog-
raphy, MDCTA, FDG-PET/CT in patients without prosthesis was 71%, 57%, 29% (86% when
combined), while specificity was 100%, 75%, 100%, respectively. Sensitivity in patients with
prosthesis was 75%, 75%, 83%, respectively (100% when combined), while specificity was 86%
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for all three modalities. Echocardiography performed best in the assessment of vegetations,
morphological valve abnormalities/dehiscence, septum defects, and fistula formation. MDCTA
performed best in the assessment of abscesses and ventricular assist device infection. FDG-PET/
CT performed best in the assessment of cardiac device infection, extracardiac infectious foci,
and alternative diagnoses.
Conclusions. This study demonstrates that the evaluated imaging-in-endocarditis-
flowchart is applicable in daily clinical practice. Echocardiography, MDCTA, and FDG-PET/
CT provide relevant complementary diagnostic information, particularly in patients with
intracardiac prosthetic material. (J Nucl Cardiol 2018)










ICD Implantable cardioverter defibrillator
LVAD Left ventricular assist device
MDCTA Multi-detector computed tomography
angiography
NVE Native valve endocarditis




Infective endocarditis is a life-threatening disease.1
Mortality rates are 15% to 20% during the acute phase
and 40% within 1 year.1,2 Neither the mortality of
endocarditis nor its incidence decreased in the past 30
years.3 Currently, the incidence of important risk factors
is increasing, e.g., aging population, implantation of
intracardiac prosthetic material, and healthcare
contact.4–9
Early and accurate diagnosis of endocarditis is
crucial, because delay in adequate treatment impairs
outcome.10,11 However, coming to a diagnosis is often
difficult and requires a multidisciplinary collaborative
approach. Therefore, the clinical diagnosis of endo-
carditis in everyday practice is based on probability
criteria that allow for standardization (European
Society of Cardiology [ESC] 2015 modified
criteria).12
The former (modified Duke) criteria still bear a high
degree of diagnostic uncertainty regarded as suboptimal,
in particular in patients with intracardiac prosthetic
material.12–15 Therefore, newer imaging techniques, in
addition to echocardiography, are now part of the
diagnostic workup for endocarditis.12 These techniques
include computed tomography (CT), 18F-fluo-
rodeoxyglucose positron emission tomography/low-
dose CT (FDG-PET/CT), and leukocyte scintigraphy
with single-photon emission computed tomography/low-
dose CT.
Recently, we published a systematic literature
review on the diagnostic value of these newer imaging
techniques in endocarditis/device infection, and pro-
posed a diagnostic flowchart (Figure 1)16. We
hypothesized that this flowchart is applicable in clinical
practice. In this study, we evaluated the adherence of
all included patients to this flowchart after its imple-
mentation in an academic medical center. The available
data on prospective head-to-head comparison of imag-
ing techniques in diagnosing endocarditis/device
infection is scarce.16–18 We hypothesized that echocar-
diography, FDG-PET/CT and electrocardiogram
(ECG)-gated multi-detector CT angiography (MDCTA)
provide complementary diagnostic information in sus-
pected endocarditis/device infection if their
performance is indicated by the flowchart. We com-
pared the accuracy of these techniques head-to-head in




We performed a prospective observational monocenter
study in an academic hospital. The study was approved by the
institutional review board (METc2016/045) and subjects
signed informed consent. From March 2016 to August 2017
all adult patients presenting with a suspicion of endocarditis/
device infection according to ‘‘the British Society for Antimi-
crobial Chemotherapy criteria’’19 were consecutively enrolled
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for the flowchart evaluation (Table 1, Figure 2). The inclusion
of patients started after the implementation of the flowchart in
our hospital protocol for infective endocarditis. Patients
receiving FDG-PET/CT, MDCTA, transthoracic (TTE), and
transoesophageal (TEE) echocardiography were included in a
head-to-head comparison of imaging accuracy for infective
endocarditis and/or infection of any component of intracardiac
prosthetic material. Patients were treated according to current
guidelines12,19,20 and expert opinion.
Intracardiac Prosthetic Material
Included prosthesis were valve plasty, biological or
mechanical prosthetic valve (sole valve or valve with vascular
prosthetic graft), pacemaker, implantable cardioverter
defibrillator (ICD), left ventricular assist device (LVAD), and
patches to close cardiac defects.
Reference Standard
The final diagnosis of endocarditis/device infection was
established by expert clinical judgement in a multidisciplinary
team of endocarditis specialists having access to all available
clinical information during hospital admission (with initial
interpretation) and follow-up of at least 2 months. The core
team consisted of infectious diseases specialists, medical
microbiologists, and cardiologists. Guiding in decision making
were the ESC 2015 modified criteria,12, but ultimately decisive
was the complete clinical evaluation and final post-hoc
judgement by the expert team.
Table 1. Data of included patients for evaluation of the adherence to the imaging-in-endocarditis-






Included patients 100 76 176
n = 105 males (60%), mean age 64 years [18–95], n = 28 deceased (16%)
Intracardiac prosthetic material N/A 76 (100%) 76 (43%)
Valvuloplasty 9 (12%) 9 (5%)
Prosthetic valve (sole) 37 (49%) 37 (21%)
Bentall procedure 8 (11%) 8 (5%)
Pacemaker/ICD 22 (29%) 22 (13%)
LVAD 6 (8%) 6 (3%)
Patch 3 (4%) 3 (2%)
TTE, n (%) 95 (95%) 71 (93%) 166 (94%)
TEE, n (%) 67 (67%) 52 (68%) 119 (68%)
FDG-PET/CT
Total, n (%) 70 (70%) 49 (64%) 119 (68%)
Cardiac*, n (%) 57 (57%) 45 (59%) 102 (58%)
MDCTA, n (%) 36 (36%) 31 (41%) 67 (38%)
Imaging workup according to
flowchart, n (%)
77 (77%)* 44 (59%)* 121 (69%)
n = 71 males (59%), mean age 65 years [20–95], n = 25 deceased (21%), mean hospital stay 56 days [0–94]
Imaging workup not according
to flowchart, n (%)
23 (23%)* 32 (41%)* 55 (31%)
n = 33 males (60%), mean age 61 years [18–84], n = 3 deceased (5%), mean hospital stay 33 days [12–94]
Head-to-head comparison 27 (27%) 19 (25%) 46 (26%)
n = 27 males (59%), mean age 66 years [27–95], n = 5 deceased (11%)
Deceased, n (%) 15 (15%) 13 (17%) 28 (16%)
Deceased, patient deceased after median follow-up time of 7 months [range 0–15]; ICD, implantable cardioverter defibrillator;
LVAD, left ventricular assist device; MDCTA, electrocardiogram-gated multidetector computed tomography angiography; n,
number of patients; N/A, not applicable; FDG-PET/CT total, 18F-fluorodeoxyglucose positron emission tomography with low-dose
computed tomography for attenuation correction; FDG-PET/CT cardiac*, good quality PET for cardiac evaluation performed after
adequate patient preparation with 24 hour low-carbohydrate, fat-allowed diet and C 6 hour fasting before the scan; SD, standard
deviation; TEE, transesophageal echocardiography; TTE, transthoracic echocardiography
*Difference of P\0.05 between the patients with and without intracardiac prosthetic material
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Flowchart Adherence
The rating, whether the imaging workup for each patient
adhered to the imaging-in-endocarditis-flowchart or not, was
determined by expert clinical judgement according to the
following rules: (1) the need to perform additional imaging
mainly depended on the persistent suspicion of endocarditis/
device infection and the existence of a plausible alternative
working diagnosis. Following the diagnostic flowchart does
not necessarily mean that all of the included imaging tech-
niques needed to be performed; (2) if a technique could not be
performed due to contraindications, but the rest of the
flowchart was followed, this was regarded as ‘‘according to
the flowchart’’; and (3) if not all planned techniques were
performed because a plausible alternative working diagnosis
was identified during the diagnostic process, this was regarded
as ‘‘according to the flowchart’’.
Echocardiography
TTE and TEE were performed according to current
guidelines.14 Findings that were regarded compatible with a
diagnosis of endocarditis/device infection included vegetations,
destructive lesions provoking valve aneurysm, perforation,
prolapse, chordae or papillary muscle rupture, abscess, pseu-
doaneurysm, and/or fistula formation. Complications regarded
indicative for endocarditis included severe valve regurgitation.
Figure 1. Diagnostic imaging-in-endocarditis-flowchart16. Reprinted from The Lancet Infectious
Diseases, 17(1), Gomes A, Glaudemans AW, Touw DJ, van Melle JP, Willems TP, Maass AH
et al., Diagnostic value of imaging in infective endocarditis: a systematic review, e1–e14, Copyright
(2017), with permission from Elsevier.
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MDCTA
MDCTAwas performed on the same camera system as used
for FDG-PET/CT (one-stop-shop principle) after intravenous
Iomeron 350 contrast infusion (flow of 4 cc/seconds; volume
individually adjusted based on duration of scanning and interscan
delay; estimated effective dose of 3 to 10 mSv). Retrospective
ECG-gating at 30% to 70% was used. Subsequently, all
anonymized scans were analyzed individually, seperately and
independently by two readers (MS, NHJP) who were blinded for
all clinical information. A locally applied, predefined scoring
system for the assessment of CTA was used for findings
consistent with endocarditis/device infection. These signs inclu-
ded vegetations, destructive lesions provoking valve aneurysm,
perforation, prolapse, chordae or papillary muscle rupture,
Figure 2. Flow of patients. BSAC, British Society for Antimicrobial Chemotherapy; ICD,
implantable cardioverter defibrillator; IE, infective endocarditis; MDCTA, multi-detector computed
tomography angiography; PET, 18F-fluorodeoxyglucose positron emission tomography/low-dose
CT; PM, pacemaker; RIE, right-sided endocarditis; TEE, transesophageal; TTE, transthoracic
echocardiography.
Journal of Nuclear Cardiology Gomes et al
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abscess, pseudoaneurysm, and/or fistula formation. Any incon-
sistencies were resolved in consensus. The final diagnosis was
reported as either ‘‘positive’’ or ‘‘negative’’, but in some cases
both readers indicated that additional information was necessary
and these scans were additionally classified as ‘‘possible’’.
FDG-PET/CT
FDG-PET/CTwas performedwith the same camera system
as used for MDCTA (one-stop-shop principle). According to the
flowchart, FDG-PET/CT could be indicated for the cardiac
diagnosis of endocarditis/device infection or to identify extrac-
ardiac infectious foci. For all scans, patients were prepared with
a 24-hour low-carbohydrate/fat-allowed diet and a minimum of
6 hours fasting. All patients were scanned from skull-base to
mid-thigh. Images were acquired on a BioGraph 64-slice mCT
(SiemensHealthcare,Knoxville, USA) and reconstructionswere
performed according to the EANM/EARL guidelines.21 FDG-
activity of 3MBq/kg of bodyweight (mean 244MBq ± 53MBq)
was injected intravenously 60 minutes before PET data acqui-
sition, according to existing guidelines.21 All scans were
accompanied by low-dose CT-scanning for attenuation correc-
tion and anatomical positioning and performed early in the
diagnostic process, preferably within 4 days and maximally 7
days after the start of antimicrobial therapy. All anonymized
scans were seperately analyzed in consensus by two experienced
readers (AWJMG, RHJAS) who were blinded for all clinical
information. Image analysis was performed using the Siemens
Syngo.via (Client version 3.0; Siemens, Erlangen, Germany).
FDG-uptake was evaluated qualitatively by pattern recognition
(homogeneous or focal/heterogeneous) and by a predefined
visual grading system using a 4-point score (1:uptake\medi-
astinum, 2:liver[ uptake[mediastinum, 3:uptake = liver,
4:uptake[ liver). Liver function (ASAT/ALAT) was checked
to decide if liver FDG-uptake could be used as a reference.22
Uptake was graded as ‘‘positive’’ for infection when tracer
uptake intensity was gradedC 2 and when the pattern was focal/
heterogeneous.
Statistical Analysis
The sensitvity of two different imaging workups
(echocardiography alone vs. with FDG-PET/MDCTA) was
compared within groups (with/without prosthesis) with two-
sided McNemar’s testing of paired proportions. Differences
between groups were compared with the two-tailed Fisher’s
exact and unpaired t tests. P values\ 0.05 are suggestive of a
difference between groups.







Intracardiac prosthetic material N/A 19 (100%)
Valvuloplasty N/A 3 (16%)





Pacemaker/ICD N/A 3 (16%)
LVAD N/A 2 (11%)
Patch N/A 2 (11%)




TTE/TEE positive, n (%) 5 (19%)* 10 (53%)*
MDCTA positive, n (%) 9 (33%) 10 (53%)
FDG-PET/CT positive, n (%)
Cardiac 2 (7%)* 11 (58%)*
Extracardiac 21 (78%) 13 (68%)
Final diagnosis endocarditis/device infection, n (%) 7 (26%)* 12 (63%)*
Final diagnosis, patient diagnosed during expert team meeting after a median follow-up time of 6 months [range 2–17]; ICD,
implantable cardioverter defibrillator; LVAD, left ventricular assist device; MDCTA, electrocardiogram-gated multidetector
computed tomography angiography; n, number of patients; N/A, not applicable; FDG-PET/CT extracardiac,18F-fluorodeoxyglucose
positron emission tomography with low-dose computed tomography for attenuation correction; FDG-PET/CT cardiac, good
quality PET for cardiac evaluation performed after adequate patient preparation with 24 hour low-carbohydrate, fat-allowed diet
and C 6 hour fasting before the scan; TEE, transesophageal echocardiography; TTE, transthoracic echocardiography. *Difference
of P\0.05 between the patients with and without intracardiac prosthetic material
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Table 3. Diagnostic accuracy of imaging techniques for the cardiac diagnosis of endocarditis/device
infection (n = 46)








Positive 5 0 5
Negative 2 20 22








Positive 4 5 9
Negative 3 15 18








Positive 2 0 2
Negative 5 20 25









Positive 9 1 10
Negative 3 6 9








Positive 9 1 10
Negative 3 6 9








Positive 10 1 11
Negative 2 6 8
Total 12 7 19
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RESULTS
Flowchart Adherence
The majority (121, 69%) of 176 enrolled patients
received an imaging workup according to the
flowchart (Figure 2, Table 1). In patients with prosthetic
material, compliance with the flowchart was
significantly lower than in patients without prosthetic
material (59% vs 77%, P = 0.0086), but there were no
statistical differences between these groups regarding
the number of performed imaging procedures (Table 1).
Major reasons for not adhering to the flowchart are
shown in Figure 2. Reasons directly after introduction of
the flowchart included unfamiliarity with it and—in the
Figure 3. True positive (A)/negative (B) imaging. Figure shows that maximum sensitivity is
reached with all techniques combined, but at the cost of decreased specificity. CTA, MDCTA; Echo,
(transthoracic and transesophageal) echocardiography; PET, FDG-PET/CT.
Gomes et al Journal of Nuclear Cardiology
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beginning—unavailability of a one-stop-shop protocol
for concurrent FDG-PET/MDCTA. Other reasons for
non-compliance were referral from another hospital,
suspicion of right-sided endocarditis (focus on TTE and
not TEE), suspicion of LVAD driveline infection (focus
on FDG-PET/CT), reluctance to use FDG-PET/CT
within 1 to 3 months after cardiothoracic surgery and
performance of FDG-PET/CT for Staphylococcus aur-
eus bacteraemia which routinely neither includes
appropriate patient preparation nor MDCTA.
Other reasons for refraining from more imaging, but
regarded as ‘‘in accordance with the flowchart’’,
included patient death before completion of the workup,
indication for emergency surgery, and inability to
perform TEE (lack of cooperation, patients’ refusal to
perfom the procedure, anatomical abnormalities, or
swallowing disorders). Reasons for refraining from
MDCTA included contraindication for the use of con-
trast agents [anaphylactic reaction or renal failure
(estimated glomerular filtration rate \ 45 mL/min)]
and cardiac tachycardia/arrhythmias.
Head-to-Head Comparison
Twenty-six percent (46/176) of the included
patients underwent echocardiography (TTE and TEE),
FDG-PET/CT, and MDCTA as indicated by the
flowchart (Figure 2, Table 1). In these patients, avail-
able for a head-to-head comparison, endocarditis/device
infection were more often diagnosed in patients with vs
without prosthesis (63% [12/19] vs 26% [7/27],
P = 0.02, Table 2). Leukocyte scintigraphy was not
performed in any patient.
Diagnostic accuracy. Echocardiography per-
formed better in patients without vs with prosthesis
(Table 3). In patients without prosthesis, echocardiog-
raphy had a better sensitivity and specificity than
MDCTA (71% and 100% vs. 57% and 75%, respec-
tively, Table 3). Conversely, in patients with prosthesis,







































































































































































































































































































































































































































































































































































































































































































cFigure 4. Illustration of the complementary information pro-
vided by different imaging techniques. Data shown for a 73-
year-old male with Enterococcus faecalis endocarditis of his
biological prosthetic aortic valve and native mitral valve
(Table 4 nr. 23, study nr. 10000246): A transthoracic echocar-
diography, two chamber view, showing the mitral valve with
vegetation; B transesophageal echocardiography, mitral com-
missural 60 view, showing the mitral valve with vegetation; C
contrast-enhanced ECG-triggered MDCTA-scan, four chamber
view, showing the mitral valve with vegetation; D fused FDG-
PET/CT-scan, sagittal and horizontal views, showing FDG-
uptake equivocal at the aortic valve (circular) and increased
focal at the mitral valve (spot).
Gomes et al Journal of Nuclear Cardiology
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(75%) and specificity (86%, Table 3). MDCTA yielded
more false-positive results in patients without prosthesis
and performed better in patients with prosthesis (positive
predictive value 44% and 90%, respectively; Table 3).
FDG-PET/CT was more sensitive in patients with vs
without prosthesis (83% vs. 29%, Table 3).
Of the 19 patients included in the head-to-head
comparison with a final diagnosis of endocarditis/device
infection, 73% (14/19) were identified by echocardiog-
raphy, 68% by MDCTA (13/19), 63% by FDG-PET/CT
(12/19), and 95% by all techniques together (18/19)
(Figure 3, Supplementary Table S1). The combined use
of all techniques identified endocarditis/device infection
in 86% of patients without prosthesis (6/7) and 100% of
patients with prosthesis (12/12).
Relative contribution. Besides the relevance of
negative scans in the clinical reasoning process, the
addition of both FDG-PET/CT and MDCTA to echocar-
diography provided clinically relevant information
regarding (extent of) the infection in 2 of 7 patients
without prosthesis (P = 0.480) and in 8 of 12 patients
with prosthesis (P = 0.013) (Table 4, Figure 4, Supple-
mentary Table S2). Including confirmation of diagnosis,
these numbers were 3 of 7 (P = 0.248) and 11 of 12
(P = 0.003) patients, respectively.
Echocardiography identified valve insufficiency and
stenosis, septum defects, pericardial fluid and assessed
ventricular function. Valve perforation and destruction
(n = 3) and fistula formation (n = 2) were only identi-
fied by echocardiography. Echocardiography identified
vegetations in 12 of 13 patients and visualized 4 of 5
abscesses. Prosthetic valve dehiscence and regurgitation
were identified with echocardiography (2 of 3) as was
valve prolapse (1 of 1). Valve plasty dehiscence (1 of 1)
however was falsely attributed to endocarditis. Echocar-
diography was false negative in 5 patients: 2 with LVAD
related infection, 2 with native valve endocarditis
(NVE), and 1 with an unclear locus of infection
(Table 4—nr. 5, study nr. 10000092, who had a cerebral
vascular accident).
MDCTA identified vegetations in 8 patients. Nota-
bly, MDCTA often identified not further specified valve
‘‘surplus’’ (non-conclusive vegetation/pannus/throm-
bus), which could retrospectively be identified as a
vegetation with a final diagnosis of endocarditis in some
cases but as false-positive in others (n = 6). MDCTA
identified abscesses (5 of 5), LVAD related infection (2
of 2), prosthetic valve dehiscence and regurgitation (2 of
3) and valve prolapse (1 of 1). Notably, it identified
valve thickening neither identified by echocardiography
nor FDG-PET/CT, retrospectively to be regarded as a
sign of endocarditis in 3 patients but as false-positive in
others (n = 7). MDCTA was false negative in 5 patients
(including 1 suboptimal scan): 4 had vegetations (3
prosthetic and 1 native valves) and 1 had T. whipplei
NVE which was only FDG-PET/CT positive. With
MDCTA coronary stenosis was identified in 20 of 46
patients (43%).
Physiological myocardial FDG-uptake was suffi-
ciently suppressed in 91% (42/46) of patients. Liver
function tests were normal in 93% (43/46) of patients. In
the other 3, liver function was affected, but FDG-uptake
was regarded within the normal range, thereby not
influencing assessment of potential pathological foci.
FDG-PET/CT identified LVAD related infection (2 of
2), pacemaker lead infection (1 of 1) and infected valves
(3 native, 6 prosthetic valves). FDG-PET/CT was false
negative in 7 patients: 5 with NVE, 1 with prosthetic
valve endocarditis (PVE) and 1 with an unclear focus of
infection (previously described). FDG-PET/CT also
identified important septic emboli and metastatic infec-
tion in 6 patients, (abscesses in the spleen and groin,
metastatic infection of the hip, shoulder, wrist, spine,
aortic root, coronary artery and lungs), other alternative
foci for infection in 16 patients and other complications
(e.g., detection of possible occult primary malignant
tumors) in 17 patients.
DISCUSSION
We evaluated the adherence to an imaging-in-
endocarditis-flowchart and showed that it is applicable
in clinical practice. We found a difference in the
adherence between patients with and without prosthe-
sis, but not in the applied imaging techniques in these
groups. Non-adherence was probably due to a similar
workup as in patients without prosthesis; while
according to the flowchart in patients with prosthesis
additional imaging techniques were required. We
revealed an optimal sensitivity for patients without
prosthesis of 86% and with prosthesis of 100%, when
echocardiography, MDCTA and FDG-PET/CT were
combined for the diagnosis of endocarditis/device
infection and demonstrated that these imaging tech-
niques provide complementary diagnostic information
if they are indicated by the flowchart. Adding FDG-
PET/MDCTA to echocardiography provides significant
relevant information in patients with prosthesis.
Therefore, our results support the use of additional
imaging techniques as indicated by the flowchart,
aiding diagnosis particularly in patients with
prosthesis.
In this study, echocardiography performed best in
identifying morphological valve abnormalities, septum
defects, and fistula formation. It was the only technique
assessing ventricular function. Echocardiography was
superior to MDCTA for the identification of vegetations
and prosthetic valve dehiscence.
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Our results confirm that MDCTA is superior to
echocardiography for the identification of abscesses and
is regarded particularly useful in patients with prosthesis
due to their high incidence of abscesses and mycotic
aneurysms.23 In addition, MDCTA identified all LVAD
infections and visualized the coronary arteries. Hereby,
it has the potential to improve prognosis by guiding
surgical management.24 MDCTA generally performed
less well in our study as compared to earlier studies
reporting a pooled sensitivity, specificity, positive and
negative predictive value of 93% to 100%, 83% to 88%,
97%, and 88%, respectively.24–26 The lower perfor-
mance in our study likely reflects factors compatible
with clinical practice: (1) instead of patients with
possible/definite endocarditis according to the modified
Duke criteria, we included patients suspected of endo-
carditis/device infection based on ‘‘the British Society
for Antimicrobial Chemotherapy criteria’’;19 (2) instead
of 64/256-slice and dual source scanners, we used a 64-
slice scanner; and (3) a different assessment of 37% (17/
46) scans between more and less experienced readers.
Our data support the combined use of FDG-PET/
MDCTA, that can be performed by hybrid camera
systems during a single visit. MDCTA was positive
while FDG-PET/CT was negative in 5 cases and
MDCTA was negative while FDG-PET/CT was positive
in 4 cases. We noticed that MDCTA identified not
further specified ‘‘surplus’’ on and thickening of valves,
falsely regarded compatible with endocarditis/device
infection. The functional data provided by FDG-PET/
CT distinguishes active from non-active deviations
identified by MDCTA, mainly in patients with prosthe-
sis.27 In the ESC 2015 modified criteria, abnormal
perivalvular FDG-uptake is a major criterion for PVE
but not for NVE, due to its low sensitivity in this
group.12,16–18,28,29 Furthermore, FDG-PET/CT can
detect extracardiac infectious complications which
might reveal an additional minor diagnostic criterion.12
In our study, FDG-PET/CT correctly identified PVE in
86% (6/7) of cases, and possibly missed one due to its
low-virulent pathogen Propionibacterium acnes. In line
with literature, FDG-PET/CT indicated for the identifi-
cation of extracardiac infectious complications or
alternative diagnosis, identified NVE in 38% (3/8) of
cases.16 FDG-PET/CT identified LVAD and pacemaker
infection. Three patients with pacemakers were included
in the head-to-head comparison and FDG-PET/CT
identified extracardiac foci in all. In one patient it
additionally showed pathological uptake at the lead, the
aortic root and right coronary artery. FDG-PET/CT also
demonstrated major clinical importance by imaging the
rest of the body, detecting multiple septic emboli,
metastatic infection, possible occult primary malignant
tumors, alternative infectious foci, and other
complications.
In our diagnostic imaging-in-endocarditis flowchart,
we advise not to perform FDG-PET/CT during a period
of 1 month after surgery. The ESC guidelines of 2017
state a 3-month period post cardiothoracic surgery in
which it is advised not to perform FDG-PET/CT for
diagnosing infective endocarditis, due to a risk of false-
positive results of the regenerative process and post-
surgical inflammation. However, the 3 month restriction
period as stated in the ESC guidelines is not based on
strong scientific evidence. There is still debate ongoing
regarding the minimal interval. Both 3 months (by the
ESC) and 1 months (by the EANM guidelines for FDG-
PET imaging in infectious diseases)21 have been pro-
posed. Instead of defining a strict post-operative period
before performing FDG-PET/CT, one should always
keep in mind the possibility of false-positive findings
post cardiothoracic surgery, also depending on used
material and surgical glue. This is also the case even
years after the implantation. Besides, this post-operative
period only accounts for the surgical area; disseminated
areas of infection outside the heart region should not
have this limitation.
A potential limitation includes selection bias for the
head-to-head comparison, as it was performed in more
complicated cases in which all imaging was obtained.
Nonetheless, as we aimed to evaluate the flowchart, the
accuracy of imaging in the patients for whom the
flowchart indicates it, is relevant. Patients with a lower
suspicion of endocarditis/device infection received clin-
ical care probably to a lower degree guided by the
imaging-in-endocarditis-flowchart. As a consequence,
selection bias might also explain the difference found in
the mortality rates of patients following the flowchart vs
patients that did not.Also the limited number of patients in
the head-to-head comparison is a limiation, especially the
relative large part (27 patients) without intracardiac
prosthetic material in which FDG-PET/CT normally is
limited and has to be interpreted carefully. However, in
this group in a large amount of patients (78%) extracardiac
findings were detected on FDG-PET/CT, emphasing the
role of this imaging technique also in this patient group.
Another limitation includes the reassessment of FDG-
PET and MDCTA by observers blinded to the clinical
data, which resulted in more conservative estimates than
in clinical practice due to their lack of information,
thereby reducing external validity.
In summary, this is the first study to investigate the
feasability, adherence, and performance of an imaging-
in-endocarditis-flowchart in patients suspected of endo-
carditis/device infection. We conclude that the
flowchart is applicable in clinical practice and of added
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value, as multimodality imaging suggested by the
flowchart provides complementary diagnostic informa-
tion in patients, especially in those with intracardiac
prosthetic material. Future studies should assess whether
the flowchart conveys a better prognosis for patients and
cost-effectiveness of this diagnostic algorithm.
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The imaging-in-endocarditis-flowchart is workable
in clinical practice. In patients in whom performance of
MDCTA and FDG-PET/CT are suggested in addition to
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chart, these techniques generally provide relevant
complementary diagnostic information, in particular in
patients with intracardiac prosthetic material.
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